Malaria Pf/Pv Rapid Test Device (WB)

The Malaria Pf/Pv Rapid Test Device is a whole-blood rapid test used to detect malaria parasite antigens. It is designed to support differentiation between Pf malaria and Pv malaria, which is useful because different malaria species may require different clinical management approaches.

• The Malaria Pf/Pv Rapid Test Device helps support fast diagnosis in febrile patients with suspected malaria exposure.
• Malaria is a mosquito-borne parasitic disease that can become severe if diagnosis and treatment are delayed.
• Pf malaria is often associated with severe disease, while Pv malaria is also globally important and may cause relapsing infection.
• Rapid diagnostic testing is useful where microscopy may not be immediately available, limited, or delayed.

The Malaria Pf/Pv Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and malaria screening environments.

Applications

• Hospitals and fever clinics
• Diagnostic laboratories
• Rural healthcare centers
• Mobile screening camps
• Travel medicine support
• Malaria-endemic regions
• Public health programs
• Point-of-care malaria screening
• International diagnostic distributors

• The Malaria Pf/Pv Rapid Test Device works on lateral flow immunochromatographic assay technology.
• A small whole-blood specimen is added to the test cassette along with buffer.
• If Pf or Pv antigens are present at or above the detectable level, antigen-antibody binding occurs on the membrane and visible test lines appear.
• The device generally includes a Pf test line, Pv test line, and control line to confirm valid test performance.

The Malaria Pf/Pv Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection and differentiation of Plasmodium falciparum and Plasmodium vivax malaria antigens in whole blood specimens.

Benefits

• Detects Plasmodium falciparum antigen
• Detects Plasmodium vivax antigen
• Supports Pf and Pv differentiation
• Uses whole blood specimen
• Rapid visual result
• No complex instrument required
• Useful in field and point-of-care settings
• Supports fast malaria screening

The Malaria Pf/Pv Rapid Test Device is designed for human whole blood specimens. Correct blood sample collection and handling are important for reliable rapid test performance.

Guidance

• Use approved whole blood specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply whole blood correctly to the sample area
• Add assay buffer as instructed
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Malaria Pf/Pv Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection and differentiation of Plasmodium falciparum and Plasmodium vivax antigens in whole blood. The listed cut-off is 50 parasites/µl.

• A Pf positive result suggests detection of Plasmodium falciparum antigen in whole blood.
• A Pv positive result suggests detection of Plasmodium vivax antigen in whole blood.
• Both Pf and Pv positive lines may indicate mixed infection or antigen detection requiring clinical interpretation.
• A negative result does not completely rule out malaria if symptoms or exposure risk remain strong.

The Malaria Pf/Pv Rapid Test Device is a professional screening aid and should not be used as the only basis for final diagnosis or treatment decisions. Microscopy, PCR, or repeat testing may be required when clinical suspicion remains high.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• A negative result may not rule out malaria in all cases
• Clinical evaluation and confirmatory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects Plasmodium falciparum antigen
• Detects Plasmodium vivax antigen
• Supports Pf/Pv differentiation
• Uses whole blood specimen
• Rapid visual result
• No complex instrument required
• Useful in field and point-of-care settings
• Suitable for international healthcare supply

Note

The Malaria Pf/Pv Rapid Test Device by LARKSOIS Pharma is designed for practical malaria screening with simple operation, fast results, and professional diagnostic support.

Steps

• Bring the test device, whole blood specimen, and assay buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the device on a clean and flat surface
• Add the required whole-blood sample to the sample area
• Add assay buffer as instructed
• Wait for the recommended reaction time
• Read the Pf, Pv, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

Pf positive suggests Plasmodium falciparum antigen detection. Pv positive suggests Plasmodium vivax antigen detection. Both Pf and Pv positive may suggest mixed infection or require further clinical interpretation.

Negative

A negative result means Pf/Pv malaria antigen was not detected at the test’s detectable level. If malaria is still suspected, repeat testing, microscopy, or PCR may be required.

Invalid

If the control line does not appear, the result is invalid and the test should be repeated with a new device.

Instructions

• Store the Malaria Pf/Pv Rapid Test Device according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and exposure history

LARKSOIS Pharma provides globally suitable diagnostic products for hospitals, laboratories, clinics, public health programs, medical distributors, and procurement agencies. The Malaria Pf/Pv Rapid Test Device (WB) is designed for practical malaria screening with simple operation, fast results, and professional diagnostic support.

Advantages

• International infectious disease rapid test portfolio
• Reliable Pf/Pv malaria antigen screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible malaria screening solution